Bradykinin 2 Receptors Mediate Long-Term Neurocognitive Deficits After Experimental Traumatic Brain Injury
- 15 November 2024
- journal article
- research article
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 41 (21-22) , 2442-2454
Abstract
The kallikrein–kinin system is one of the first inflammatory pathways to be activated following traumatic brain injury (TBI) and has been shown to exacerbate brain edema formation in the acute phase through activation of bradykinin 2 receptors (B2R). However, the influence of B2R on chronic post-traumatic damage and outcome is unclear. In the current study, we assessed long-term effects of B2R-knockout (KO) after experimental TBI. B2R KO mice (heterozygous, homozygous) and wild-type (WT) littermates ( n = 10/group) were subjected to controlled cortical impact (CCI) TBI. Lesion size was evaluated by magnetic resonance imaging up to 90 days after CCI. Motor and memory function were regularly assessed by Neurological Severity Score, Beam Walk, and Barnes maze test. Ninety days after TBI, brains were harvested for immunohistochemical analysis. There was no difference in cortical lesion size between B2R-deficient and WT animals 3 months after injury; however, hippocampal damage was reduced in B2R KO mice ( p = 0.03). Protection of hippocampal tissue was accompanied by a significant improvement of learning and memory function 3 months after TBI ( p = 0.02 WT vs. KO), whereas motor function was not influenced. Scar formation and astrogliosis were unaffected, but B2R deficiency led to a gene-dose-dependent attenuation of microglial activation and a reduction of CD45+ cells 3 months after TBI in cortex ( p = 0.0003) and hippocampus ( p < 0.0001). These results suggest that chronic hippocampal neurodegeneration and subsequent cognitive impairment are mediated by prolonged neuroinflammation and B2R. Inhibition of B2R may therefore represent a novel strategy to reduce long-term neurocognitive deficits after TBI.Keywords
This publication has 74 references indexed in Scilit:
- Long-term outcome after severe traumatic brain injury: a systematic literature reviewActa Neurochirurgica, 2022
- Functional Outcomes Over the First Year After Moderate to Severe Traumatic Brain Injury in the Prospective, Longitudinal TRACK-TBI StudyJAMA Neurology, 2021
- Assessment of spatial learning and memory in the Barnes maze task in rodents—methodological considerationNaunyn-Schmiedeberg's Archives of Pharmacology, 2018
- Bradykinin B2 receptor is essential to running-induced cell proliferation in the adult mouse hippocampusBrain Structure and Function, 2018
- Cognitive deficits develop 1 month after diffuse brain injury and are exaggerated by microglia-associated reactivity to peripheral immune challengeBrain, Behavior, and Immunity, 2016
- Pericytes are involved in the pathogenesis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathyAnnals of Neurology, 2015
- Novel mGluR5 Positive Allosteric Modulator Improves Functional Recovery, Attenuates Neurodegeneration, and Alters Microglial Polarization after Experimental Traumatic Brain InjuryNeurotherapeutics, 2014
- HOE-140, an antagonist of B2 receptor, protects against memory deficits and brain damage induced by moderate lateral fluid percussion injury in micePsychopharmacology, 2013
- Kinins and kinin receptors in the nervous systemNeurochemistry International, 1995
- Activation of plasminogen by human plasma kallikreinBiochemical and Biophysical Research Communications, 1969